HEART RHYTHM DISTURBANCES
QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients
Mark C. Haigney, MD*,*,
Wojciech Zareba, MD, PhD ,
Philip J. Gentlesk, MD*,
Robert E. Goldstein, MD*,
Michael Illovsky, MD*,
Scott McNitt, PhD ,
Mark L. Andrews, PhD ,
Arthur J. Moss, MD the MADIT II Investigators
* Division of Cardiology, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland
Division of Cardiology, Department of Medicine, University of Rochester School of Medicine, Rochester, New York
Manuscript received March 31, 2004;
revised manuscript received April 28, 2004,
accepted June 7, 2004.
* Reprint requests and correspondence: Dr. Mark C. Haigney, Division of Cardiology, Department of Medicine, Uniformed Services University of the Health Sciences A3060, USUHS, 4301 Jones Bridge Road, Bethesda, Maryland 20814 (Email: MCPH{at}aol.com).
OBJECTIVES: This study aimed to determine whether increased QT interval variability is associated with an increased risk for ventricular tachycardia (VT) or ventricular fibrillation (VF), documented by interrogation of the implantable cardioverter-defibrillator (ICD), in patients enrolled in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II.
BACKGROUND: Unstable repolarization has been proposed as a risk factor for re-entrant arrhythmias, but confirmatory data from clinical trials are lacking.
METHODS: The QT variability was assessed in 10-min, resting high-resolution electrocardiogram recordings at study entry using a semiautomated algorithm that measured beat-to-beat QT duration in 817 MADIT II patients. The incidence of VT/VF requiring device therapy was determined by ICD interrogation.
RESULTS: Median normalized QT variability (QTVN) was 0.179 and 0.125, respectively, in patients with VT/VF versus those without VT/VF (p = 0.001); QTVI (QTVN adjusted for heart rate variance) also was significantly (p < 0.05) higher in VT/VF patients than in those without VT/VF. Either QTVN or QTVI was linked with a significantly higher probability of VT/VF: two-year risk of VT/VF from Kaplan-Meier curves was 40% in highest quartile versus 21% in lower quartiles for QTVN, and 37% versus 22% for QTVI (p < 0.05 for each). In multivariate Cox regression models adjusting for clinical covariates (race, New York Heart Association functional class, time after myocardial infarction), top-quartile QTVI and QTVN were independently associated with VT/VF (hazard ratio for QTVN 2.18, 95%confidence interval [CI] 1.34 to 3.55, p = 0.002; hazard ratio for QTVI 1.80, 95% CI 1.09 to 2.95, p = 0.021).
CONCLUSIONS: In postinfarction patients with severe left ventricular dysfunction, increased QT variability, a marker of repolarization lability, is associated with an increased risk for VT/VF.
|
Abbreviations and Acronyms
| | CI = confidence interval | | HRv = heart rate variance | | ICD = implantable cardioverter-defibrillator | | MADIT = Multicenter Automatic Defibrillator Implantation Trial | | QTVI = QT variability index | | QTVN = QT variability (numerator) | | VF = ventricular fibrillation | | VT = ventricular tachycardia |
|
This article has been cited by other articles:

|
 |

|
 |
 
R. J. Myerburg, V. Reddy, and A. Castellanos
Indications for implantable cardioverter-defibrillators based on evidence and judgment.
J. Am. Coll. Cardiol.,
August 25, 2009;
54(9):
747 - 763.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Piccirillo, D. Magri, M. Ogawa, J. Song, V. J. Chong, S. Han, B. Joung, E.-K. Choi, S. Hwang, L. S. Chen, et al.
Autonomic Nervous System Activity Measured Directly and QT Interval Variability in Normal and Pacing-Induced Tachycardia Heart Failure Dogs.
J. Am. Coll. Cardiol.,
August 25, 2009;
54(9):
840 - 850.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. D. Berger
QT Interval Variability Is It a Measure of Autonomic Activity?
J. Am. Coll. Cardiol.,
August 25, 2009;
54(9):
851 - 852.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. G. Tereshchenko, B. J. Fetics, P. P. Domitrovich, B. D. Lindsay, and R. D. Berger
Prediction of Ventricular Tachyarrhythmias by Intracardiac Repolarization Variability Analysis
Circ Arrhythm Electrophysiol,
June 1, 2009;
2(3):
276 - 284.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-P. Couderc, S. Kaab, M. Hinterseer, S. McNitt, X. Xia, A. Fossa, B. M. Beckmann, S. Polonsky, and W. Zareba
Baseline Values and Sotalol-Induced Changes of Ventricular Repolarization Duration, Heterogeneity, and Instability in Patients With a History of Drug-Induced Torsades de Pointes
J. Clin. Pharmacol.,
January 1, 2009;
49(1):
6 - 16.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Myerburg
Implantable Cardioverter-Defibrillators after Myocardial Infarction
N. Engl. J. Med.,
November 20, 2008;
359(21):
2245 - 2253.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Goldberger, M. E. Cain, S. H. Hohnloser, A. H. Kadish, B. P. Knight, M. S. Lauer, B. J. Maron, R. L. Page, R. S. Passman, D. Siscovick, et al.
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death: A Scientific Statement From the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention
J. Am. Coll. Cardiol.,
September 30, 2008;
52(14):
1179 - 1199.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Goldberger, M. E. Cain, S. H. Hohnloser, A. H. Kadish, B. P. Knight, M. S. Lauer, B. J. Maron, R. L. Page, R. S. Passman, D. Siscovick, et al.
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death: A Scientific Statement From the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention
Circulation,
September 30, 2008;
118(14):
1497 - 1518.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Ding, W. Hua, H. Niu, K. Chen, and S. Zhang
Primary prevention of sudden cardiac death using implantable cardioverter defibrillators
Europace,
September 1, 2008;
10(9):
1034 - 1041.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-P. Couderc, W. Zareba, S. McNitt, P. Maison-Blanche, and A. J. Moss
Repolarization variability in the risk stratification of MADIT II patients
Europace,
September 1, 2007;
9(9):
717 - 723.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Iacoviello, C. Forleo, P. Guida, R. Romito, A. Sorgente, S. Sorrentino, S. Catucci, F. Mastropasqua, and M. Pitzalis
Ventricular Repolarization Dynamicity Provides Independent Prognostic Information Toward Major Arrhythmic Events in Patients With Idiopathic Dilated Cardiomyopathy
J. Am. Coll. Cardiol.,
July 17, 2007;
50(3):
225 - 231.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Zareba
Holter Electrocardiogram Parameters in Risk Stratification of Arrhythmic Events in Idiopathic Dilated Cardiomyopathy: More Studies Are Needed
J. Am. Coll. Cardiol.,
July 17, 2007;
50(3):
232 - 233.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.S. Kostapanos, E.N. Liberopoulos, J.A. Goudevenos, D.P. Mikhailidis, and M.S. Elisaf
Do statins have an antiarrhythmic activity?
Cardiovasc Res,
July 1, 2007;
75(1):
10 - 20.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Piccirillo, D. Magri, S. Matera, M. Magnanti, A. Torrini, E. Pasquazzi, E. Schifano, S. Velitti, V. Marigliano, R. Quaglione, et al.
QT variability strongly predicts sudden cardiac death in asymptomatic subjects with mild or moderate left ventricular systolic dysfunction: a prospective study
Eur. Heart J.,
June 1, 2007;
28(11):
1344 - 1350.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Pfeufer, S. Jalilzadeh, S. Perz, J. C. Mueller, M. Hinterseer, T. Illig, M. Akyol, C. Huth, A. Schopfer-Wendels, B. Kuch, et al.
Common Variants in Myocardial Ion Channel Genes Modify the QT Interval in the General Population: Results From the KORA Study
Circ. Res.,
April 1, 2005;
96(6):
693 - 701.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|